| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 338 | 2020 |
| Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection J Perera, L Meng, F Meng, H Huang Proceedings of the National Academy of Sciences 110 (42), 17011-17016, 2013 | 145 | 2013 |
| Clinical validation of the tempus xT next-generation targeted oncology sequencing assay N Beaubier, R Tell, D Lau, JR Parsons, S Bush, J Perera, S Sorrells, ... Oncotarget 10 (24), 2384, 2019 | 138 | 2019 |
| Integrated genomic profiling expands clinical options for patients with cancer N Beaubier, M Bontrager, R Huether, C Igartua, D Lau, R Tell, AM Bobe, ... Nature biotechnology 37 (11), 1351-1360, 2019 | 128 | 2019 |
| A pan-cancer organoid platform for precision medicine BM Larsen, M Kannan, LF Langer, BD Leibowitz, A Bentaieb, A Cancino, ... Cell reports 36 (4), 2021 | 63 | 2021 |
| The development and function of thymic B cells J Perera, H Huang Cellular and molecular life sciences 72, 2657-2663, 2015 | 58 | 2015 |
| Self-antigen-driven thymic B cell class switching promotes T cell central tolerance J Perera, Z Zheng, S Li, H Gudjonson, O Kalinina, JIC Benichou, KE Block, ... Cell reports 17 (2), 387-398, 2016 | 52 | 2016 |
| Autoreactive T and B cells induce the development of bronchus-associated lymphoid tissue in the lung RA Shilling, JW Williams, J Perera, E Berry, Q Wu, OW Cummings, ... American journal of respiratory cell and molecular biology 48 (4), 406-414, 2013 | 34 | 2013 |
| Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA JD Finkle, H Boulos, TM Driessen, C Lo, RA Blidner, A Hafez, AA Khan, ... NPJ Precision Oncology 5 (1), 63, 2021 | 23 | 2021 |
| Detection of human leukocyte antigen class I loss of heterozygosity in solid tumor types by next-generation DNA sequencing J Perera, B Mapes, D Lau, A Salahudeen, A Khan Lung 26, 50, 2019 | 10 | 2019 |
| Adversarial deep learning for microsatellite instability prediction from histopathology slides R Zhang, BL Osinski, TJ Taxter, J Perera, DJ Lau, AA Khan Proceedings of the 1st Conference on Medical Imaging with Deep Learning …, 2018 | 8 | 2018 |
| Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis J Perera, X Liu, Y Zhou, NE Joseph, L Meng, JR Turner, H Huang Arthritis & Rheumatism 65 (11), 2847-2856, 2013 | 5 | 2013 |
| Detection of human leukocyte antigen loss of heterozygosity J Perera US Patent 11,081,210, 2021 | 4 | 2021 |
| Graph-pMHC: graph neural network approach to mhc class II peptide presentation and antibody immunogenicity WJ Thrift, J Perera, S Cohen, NW Lounsbury, HR Gurung, CM Rose, ... Briefings in Bioinformatics 25 (3), bbae123, 2024 | 2 | 2024 |
| 491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future … J Molina, W Go, S Kopetz, D Simeone, S Patel, Y Lin, K Liechty, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
| Methods and systems for detecting microsatellite instability of a cancer in a liquid biopsy assay A Lozac'hmeur, AA Khan, J Perera, D Lau, A Hafez US Patent App. 16/945,588, 2021 | 2 | 2021 |
| Microsatellite instability detection with cell-free DNA next-generation sequencing A Lozac’hmeur, A Hafez, J Perera, D Lau, AA Khan Cancer 7 (5), 2019 | 2 | 2019 |
| Cloning of a hamster anti-mouse CD79B antibody sequences and identification of a new hamster immunoglobulin lambda constant IGLC gene region R Haggart, J Perera, H Huang Immunogenetics 65, 473-478, 2013 | 2 | 2013 |
| TCR/BCR profiling using enrichment with pools of capture probes J Perera, T Harding, B Mineo, AA Khan, R Blidner, JL Malinauskas US Patent 11,414,700, 2022 | 1 | 2022 |
| BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T … J Molina, W Go, S Kopetz, D Simeone, S Patel, Y Lin, K Liechty, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 9, A522-A522, 2021 | 1 | 2021 |
